EcoDrugPlus

40s Ribosomal Protein S23

Ensembl ID : ENSSFOG00015003498
Gene Symbol: LOC108929789
3 Cross references
382 Possible Orthologues:

40s Ribosomal Protein S25

Ensembl ID : ENSSFOG00015030390
Gene Symbol: LOC108921540
3 Cross references
449 Possible Orthologues:

40s Ribosomal Protein S25-Like

Ensembl ID : ENSSFOG00015032370
Gene Symbol: LOC108932155
3 Cross references
449 Possible Orthologues:

40s Ribosomal Protein S26

Ensembl ID : ENSSFOG00015004734
Gene Symbol: LOC108939174
3 Cross references
414 Possible Orthologues:

40s Ribosomal Protein S3a

Ensembl ID : ENSSFOG00015033020
Gene Symbol: LOC108936705
3 Cross references
318 Possible Orthologues:

40s Ribosomal Protein S4

Ensembl ID : ENSSFOG00015031788
Gene Symbol: LOC108934462
3 Cross references
447 Possible Orthologues:

40s Ribosomal Protein S4-Like

Ensembl ID : ENSSFOG00015009888
Gene Symbol: LOC108922964
2 Cross references
492 Possible Orthologues:

40s Ribosomal Protein S5-Like

Ensembl ID : ENSSFOG00015019773
Gene Symbol: LOC108927378
2 Cross references
264 Possible Orthologues:

5'-Nucleotidase Ecto

Ensembl ID : ENSSFOG00015000128
Gene Symbol: NT5E
3 Cross references
250 Possible Orthologues:

5-Hydroxytryptamine Receptor 1d

Ensembl ID : ENSSFOG00015010780
Gene Symbol: HTR1D
1 Cross references
64 Possible Orthologues:

5-Hydroxytryptamine Receptor 1e

Ensembl ID : ENSSFOG00015022072
Gene Symbol: HTR1E
3 Cross references
155 Possible Orthologues:

5-Hydroxytryptamine Receptor 2a

Ensembl ID : ENSSFOG00015002489
Gene Symbol: HTR2A
3 Cross references
219 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).